Methods of predicting methotrexate efficacy and toxicity

Details for Australian Patent Application No. 2006239279 (hide)

Owner Prometheus Laboratories, Inc.

Inventors Dervieux, Thierry

Agent Watermark

Pub. Number AU-A-2006239279

PCT Pub. Number WO2006/116684

Priority 11/380,171 25.04.06 US; 60/731,598 27.10.05 US; 60/676,442 28.04.05 US

Filing date 26 April 2006

Wipo publication date 2 November 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116684 Priority application(s): WO2006/116684

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239284-Micronized tanaproget and compostions containing same

2006239263-Proximity sensor